Conferences
Upcoming MDPI Conferences (1)
Barcelona
Dear Colleagues,
It is my great pleasure to welcome you to Pharmaceutics 2027 – From Biopharmaceutics to Clinical Pharmaceutics, taking place in Barcelona, Spain from 28–30 June 2027. This milestone conference brings together leading researchers, clinicians, industry professionals, and innovators from across the globe to exchange cutting-edge knowledge, discuss emerging trends, and forge vital partnerships across the pharmaceutical sciences.
The theme of this year's conference reflects our ambition to explore the entire continuum of pharmaceutical development. We will span the full spectrum from the fundamental principles of biopharmaceutics and innovative drug formulation to advanced drug delivery systems, pharmaceutical manufacturing, translational research, and clinical applications. Through an engaging program of keynote lectures, oral presentations, interactive poster sessions, and curated networking events, participants will gain deep insights into the latest scientific breakthroughs and the regulatory or technical challenges shaping the future of our field.
Pharmaceutics 2027 aims to provide a dynamic, interdisciplinary platform. We actively encourage researchers from academia, industry, and healthcare sectors to participate—whether by presenting groundbreaking work, sharing unique technical expertise, or engaging in the vibrant discussions that drive innovation and ultimately improve patient outcomes.
Beyond the formal scientific sessions, the conference offers invaluable opportunities to establish fresh alliances, strengthen global professional networks, and connect with peers who give our international community its collective scientific weight.
I look forward to welcoming you to Barcelona for what promises to be an inspiring, collaborative, and highly productive conference.
Sessions:
-
S1. Drug Delivery and Controlled Release
-
S2. Pharmaceutical Technology, Manufacturing and Devices
-
S3. Nanomedicine and Nanotechnology
-
S4. Physical Pharmacy and Formulation
-
S5. Biopharmaceutics
-
S6. Pharmacokinetics, Pharmacodynamics, and Clinical Pharmaceutics
Important Dates:
- Abstract submission deadline: January 29, 2027
- Abstract acceptance notification: March 01, 2027
- Early bird registration deadline: April 05, 2027
- Regular registration deadline: May 26, 2027
- Late registration deadline: June 23, 2027
Click here to submit your abstract: sciforum.net/submissions/Pharmaceutics2027/link/1
Click here to register for the conference: Registration
Prof. Dr. Patrick J. Sinko
Pharmaceutics 2027 Chair
Upcoming Partner Conferences (3)
Ankara, Turkiye
The Journal of Pharmaceutical and BioTech Industry (ISSN 2813-9380) is proud to be sponsoring the 22nd International Pharmaceutical Technology Symposium (IPTS-2026). This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in critical industry-related discussions with the public.
For 44 years, IPTS has set a tradition of bringing together representatives from academia, industry, regulatory authorities, and postgraduate students to discuss and collaborate on the latest issues and hot topics in the fields of drug delivery, formulation development, manufacturing and regulatory sciences concerning pharmaceuticals, as well as cosmetics, supplements and medical devices.
IPTS-2026 will be held on 9–11 September 2026 at the Bilkent Hotel Convention Center in Ankara. IPTS will comprise a 3-day scientific program, with plenary lectures, scientific and industrial sessions in parallel halls, short courses, scientific awards and lively social sessions.
The main theme of the 22nd IPTS will be "Pharmaceutical Technology at the Crossroads of Innovation: AI, Nanotech, and Beyond". In this context, a comprehensive program is being prepared consisting of scientific sessions focusing on applications of enabling tools such as artificial intelligence and machine learning, nanobiotechnology, 3D and 4D printing, and innovative drug delivery systems and their implications in pharmaceuticals, regulatory science and patient access to new and safe medicines and healthcare.
The industrial sessions will be dedicated to Innovation Leading Regulatory Science in Healthcare with the following sessions/minisymposia:
- “Biological Products and Biosimilars”;
- “Cosmeceuticals: Innovation, formulation, manufacturing and regulation”;
- “Bioequivalence and API sameness requirements of complex products”;
- “Development and Regulation of Dietary Supplements: Is the Science built into the consumer product?”;
- “Sustainability in Pharmaceutical Industry and AI”.
The industrial sessions will be finalized with a panel discussion and open forum on “Localization of medicines, medical devices and vaccines” with representatives from the Ministry of Health and the Ministry of Industry and Technology, the pharmaceutical and biotech industries, research centers, CROs and scientists.
For more information, please visit the official conference website:
Piscataway, NJ, USA
The Journal of Pharmaceutical and BioTech Industry (ISSN 2813-9380) is proud to sponsor The Innovations in Dermatological Sciences Conference 2026. This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in academic activities.
The Innovations in Dermatological Sciences Conference 2026 brings together 70–100 leading researchers, industry professionals, and innovators to explore advances in skin science and topical drug development. The theme for the 2026 conference is “Skin Science without Silos: Advancing Topical Product Development”.
Conference topics include the following:
- Novel compounds for pharmaceutical, personal care, and cosmetic formulations;
- Delivery of actives from topically applied formulations to skin, hair follicles, and nails;
- Solutions to challenges in skin delivery, such as formulation strategies and novel carriers for actives;
- In vitro active release testing (IVRT), in vitro active permeability testing (IVPT), and in vivo testing;
- Skin biology in health and disease (specific topics can vary in different years);
- Natural cosmetic and personal care actives for skin formulations;
- Novel formulation excipients;
- Reformulation of existing products;
- Regulatory aspects of skin products.
For more information, please visit the official conference website: https://tinyurl.com/rr2dsy5d.
Toronto, ON, Canada
The Journal of Pharmaceutical and BioTech Industry (ISSN 2813-9380) is proud to be sponsoring the 2026 CRS Women’s Health Symposium. This sponsorship highlights the journal’s commitment to supporting the academic community and global leaders in cancer, pregnancy, and translational research.
The Women’s Health Symposium is a two-day, multidisciplinary event focused on innovations in drug delivery, biomedical technology development, and clinical translation in women’s health. The symposium brings together leading international experts, clinicians, researchers, and trainees to explore cutting-edge advances across key areas of women’s health.
The program features thematic sessions on cancer, infectious diseases and reproductive health, local vaginal and mucosal drug delivery, and pregnancy-related diagnostics, treatments, and models, highlighting both fundamental research and translational applications. Attendees will hear from global leaders in academia and industry, alongside opportunities to engage with emerging research through trainee pitch presentations, poster sessions, and networking events.
The program highlights:
- Keynote Addresses: Insights from distinguished academic and industry leaders.
- Research Showcases: A series of oral and poster presentations highlighting the latest advancements in the field.
- Networking: A networking reception connecting research trainees, industry professionals, global health and government representatives, and keynote speakers.
https://www.eventbrite.ca/e/crs-womens-health-symposium-registration-1986925381302
